Cell biobank as a necessary infrastructure for the development and implementation of mesenchymal stem cell-based therapy in the treatment of anthracycline-induced cardiotoxicity. Literature review and own data

Cell biobank as a necessary infrastructure for the development and implementation of mesenchymal stem cell-based therapy in the treatment of anthracycline-induced cardiotoxicity. Literature review and own data

Cardiovascular diseases, along with cancer, are the leading causes of death worldwide. Although modern pharmacological treatment of various cardiomyopathies can slow the development of myocardial dysfunction, they have limited effectiveness in patients with end-stage disease. Many researchers believ...

Full description

Bibliographic Details
Main Authors: L. Yu. Grivtsova, O. E. Popovkina, N. N. Dukhova, O. A. Politiko, V. V. Yuzhakov, L. A. Lepekhina, S. Sh. Kalsina, S. A. Ivanov, A. D. Kaprin
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2020-12-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
мезенхимальные стволовые клетки
кардиомиобласты
клеточный биобанк
антрациклины
кардиомиоциты
кардиотоксичность
Online Access:https://cardiovascular.elpub.ru/jour/article/view/2733

Similar Items

Similar Items